Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used due to their profound efficacy in glycemic control and weight management. Real-world observations have revealed potential neuropsychiatric adverse events (AEs) associated with GLP-1RAs. This study aimed to compr...
        Saved in:
      
    
          | Main Authors: | , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | 
            Cambridge University Press
    
        2025-01-01
     | 
| Series: | European Psychiatry | 
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933824018030/type/journal_article | 
| Tags: | 
       Add Tag    
     
      No Tags, Be the first to tag this record!
   
 |